View in EDS PDF Full Text

Leveraging molecular targeted drugs and immune checkpoint inhibitors treat advanced thyroid carcinoma to achieve thyroid carcinoma redifferentiation.

Saved in:
Bibliographic Details
Title: Leveraging molecular targeted drugs and immune checkpoint inhibitors treat advanced thyroid carcinoma to achieve thyroid carcinoma redifferentiation.
Authors: Su JY; Hangzhou Hospital of Traditional Chinese Medicine Affiliated to Zhejiang Chinese Medical University Hangzhou 310007, Zhejiang, China.; Tongde Hospital of Zhejiang Province Hangzhou 310012, Zhejiang, China., Huang T; Hangzhou Hospital of Traditional Chinese Medicine Affiliated to Zhejiang Chinese Medical University Hangzhou 310007, Zhejiang, China., Zhang JL; Hangzhou Hospital of Traditional Chinese Medicine Affiliated to Zhejiang Chinese Medical University Hangzhou 310007, Zhejiang, China., Lu JH; Hangzhou Hospital of Traditional Chinese Medicine Affiliated to Zhejiang Chinese Medical University Hangzhou 310007, Zhejiang, China., Wang ML; Hangzhou Hospital of Traditional Chinese Medicine Affiliated to Zhejiang Chinese Medical University Hangzhou 310007, Zhejiang, China., Yan J; Hangzhou Hospital of Traditional Chinese Medicine Affiliated to Zhejiang Chinese Medical University Hangzhou 310007, Zhejiang, China., Lin RB; Hangzhou Hospital of Traditional Chinese Medicine Affiliated to Zhejiang Chinese Medical University Hangzhou 310007, Zhejiang, China., Lin SY; Department of Oncology, The First Affiliated Hospital of Zhejiang Chinese Medical University Hangzhou 310000, Zhejiang, China., Wang J; Hangzhou Hospital of Traditional Chinese Medicine Affiliated to Zhejiang Chinese Medical University Hangzhou 310007, Zhejiang, China.
Source: American journal of cancer research [Am J Cancer Res] 2024 Feb 15; Vol. 14 (2), pp. 407-428. Date of Electronic Publication: 2024 Feb 15 (Print Publication: 2024).
Publication Type: Journal Article; Review
Journal Info: Publisher: e-Century Pub. Corp Country of Publication: United States NLM ID: 101549944 Publication Model: eCollection Cited Medium: Print ISSN: 2156-6976 (Print) Linking ISSN: 21566976 NLM ISO Abbreviation: Am J Cancer Res Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
FullText Links:
  – Type: pdflink
Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 38455407
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Leveraging molecular targeted drugs and immune checkpoint inhibitors treat advanced thyroid carcinoma to achieve thyroid carcinoma redifferentiation.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Su+JY%22">Su JY</searchLink>; Hangzhou Hospital of Traditional Chinese Medicine Affiliated to Zhejiang Chinese Medical University Hangzhou 310007, Zhejiang, China.; Tongde Hospital of Zhejiang Province Hangzhou 310012, Zhejiang, China.<br /><searchLink fieldCode="AU" term="%22Huang+T%22">Huang T</searchLink>; Hangzhou Hospital of Traditional Chinese Medicine Affiliated to Zhejiang Chinese Medical University Hangzhou 310007, Zhejiang, China.<br /><searchLink fieldCode="AU" term="%22Zhang+JL%22">Zhang JL</searchLink>; Hangzhou Hospital of Traditional Chinese Medicine Affiliated to Zhejiang Chinese Medical University Hangzhou 310007, Zhejiang, China.<br /><searchLink fieldCode="AU" term="%22Lu+JH%22">Lu JH</searchLink>; Hangzhou Hospital of Traditional Chinese Medicine Affiliated to Zhejiang Chinese Medical University Hangzhou 310007, Zhejiang, China.<br /><searchLink fieldCode="AU" term="%22Wang+ML%22">Wang ML</searchLink>; Hangzhou Hospital of Traditional Chinese Medicine Affiliated to Zhejiang Chinese Medical University Hangzhou 310007, Zhejiang, China.<br /><searchLink fieldCode="AU" term="%22Yan+J%22">Yan J</searchLink>; Hangzhou Hospital of Traditional Chinese Medicine Affiliated to Zhejiang Chinese Medical University Hangzhou 310007, Zhejiang, China.<br /><searchLink fieldCode="AU" term="%22Lin+RB%22">Lin RB</searchLink>; Hangzhou Hospital of Traditional Chinese Medicine Affiliated to Zhejiang Chinese Medical University Hangzhou 310007, Zhejiang, China.<br /><searchLink fieldCode="AU" term="%22Lin+SY%22">Lin SY</searchLink>; Department of Oncology, The First Affiliated Hospital of Zhejiang Chinese Medical University Hangzhou 310000, Zhejiang, China.<br /><searchLink fieldCode="AU" term="%22Wang+J%22">Wang J</searchLink>; Hangzhou Hospital of Traditional Chinese Medicine Affiliated to Zhejiang Chinese Medical University Hangzhou 310007, Zhejiang, China.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101549944%22">American journal of cancer research</searchLink> [Am J Cancer Res] 2024 Feb 15; Vol. 14 (2), pp. 407-428. <i>Date of Electronic Publication: </i>2024 Feb 15 (<i>Print Publication: </i>2024).
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Review
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22e-Century+Pub%2E+Corp%22">e-Century Pub. Corp </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101549944 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Print <i>ISSN: </i>2156-6976 (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2221566976%22">21566976 </searchLink><i>NLM ISO Abbreviation: </i>Am J Cancer Res <i>Subsets: </i>PubMed not MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=38455407
RecordInfo BibRecord:
  BibEntity:
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 407
    Titles:
      – TitleFull: Leveraging molecular targeted drugs and immune checkpoint inhibitors treat advanced thyroid carcinoma to achieve thyroid carcinoma redifferentiation.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Su JY
      – PersonEntity:
          Name:
            NameFull: Huang T
      – PersonEntity:
          Name:
            NameFull: Zhang JL
      – PersonEntity:
          Name:
            NameFull: Lu JH
      – PersonEntity:
          Name:
            NameFull: Wang ML
      – PersonEntity:
          Name:
            NameFull: Yan J
      – PersonEntity:
          Name:
            NameFull: Lin RB
      – PersonEntity:
          Name:
            NameFull: Lin SY
      – PersonEntity:
          Name:
            NameFull: Wang J
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 15
              M: 02
              Text: 2024 Feb 15
              Type: published
              Y: 2024
          Identifiers:
            – Type: issn-print
              Value: 2156-6976
          Numbering:
            – Type: volume
              Value: 14
            – Type: issue
              Value: 2
          Titles:
            – TitleFull: American journal of cancer research
              Type: main
ResultId 1